Article
Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension
5 Mar 2023
Abstract excerpt
Background A recent Mendelian randomization (MR) did not support an effect of the lead interleukin-6 receptor (IL-6 R) variant on risk of pulmonary arterial hypertension (PAH). Thus, we used two sets of genetic instrumental variants (IVs) and publicly available PAH genome-wide association studies (GWAS) to reassess the genetic causal link between IL-6 signaling and PAH.Methods Six independent IL-6 signaling and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
